Pharmacokinetic drug-drug interactions of tyrosine kinase inhibitors: A focus on cytochrome P450, transporters, and acid suppression therapy-Reference-Cited by-同舟云学术

Pharmacokinetic drug-drug interactions of tyrosine kinase inhibitors: A focus on cytochrome P450, transporters, and acid suppression therapy

Published:2016-12-07 Issue:3 Volume:35 Page:259-280
ISSN:0278-0232
Container-title:Hematological Oncology
language:en
Short-container-title:Hematological Oncology

Author:

Gay Caroline¹,Toulet Delphine¹,Le Corre Pascal¹²^ORCID

Affiliation:

1. Pôle Pharmacie; Service Hospitalo-Universitaire de Pharmacie; CHU de Rennes Rennes Cedex France

2. Laboratoire de Pharmacie Galénique, Biopharmacie et Pharmacie Clinique; IRSET U1085, Faculté de Pharmacie, Université de Rennes 1; Rennes Cedex France

Publisher

Wiley

Subject

Cancer Research,Oncology,Hematology,General Medicine

Reference123 articles.

1. Tyrosine kinases as targets for cancer therapy;Krause;N Engl J Med,2005

2. Targeted cancer therapy;Sawyers;Nature,2004

3. Targeting tyrosine kinases in cancer: the second wave;Baselga;Science,2006

4. Life expectancy of patients with chronic myeloid leukemia approaches the life expectancy of the general population;Bower;J Clin Oncol,2016

5. Management of adverse events associated with tyrosine kinase inhibitors in chronic myeloid leukemia;Rea;Ann Hematol,2015

Cited by 42 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pharmaceutical care in the screening process of phase I oncohaematological clinical trials;European Journal of Hospital Pharmacy;2024-08-13

2. Phenotype versus genotype to optimize cancer dosing in the clinical setting—focus on 5‐fluorouracil and tyrosine kinase inhibitors;Pharmacology Research & Perspectives;2024-03

3. Chronopharmakologie mit dem Schwerpunkt Chronopharmakokinetik;Praxishandbuch Chronomedizin;2024

4. Tyrosine kinase inhibitors: the role of pharmacokinetics and pharmacogenetics;Expert Opinion on Drug Metabolism & Toxicology;2023-11-02

5. Validation of an LC-MS/MS assay for rapid and simultaneous quantification of 21 kinase inhibitors in human plasma and serum for therapeutic drug monitoring;Journal of Chromatography B;2023-09